CoChat
Sign Up
Cited by 57

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system

Schonkeren, Simone L., Massen, Maartje, van der Horst, Raisa, Koch, Alexander, Vaes, Nathalie, Melotte, Veerle·2019·neurogenetics
DOI 10.1007/s10048-019-00587-0PMC PMC6754360
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10048-019-00587-0

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 87

  1. Zhong C, Zhou YK, Yang SS, Zhao JF, Zhu XL, Chen HH, Chen PC, Huang LQ, Huang X (2015) Developmental expression of the N-myc downstream regulated gene (Ndrg) family during Xenopus tropicalis embryogenesis. Int J Dev Biol 59(10–12):511–517. https://doi.org/10.1387/ijdb.150178xh · DOI
  2. Melotte V, Qu X, Ongenaert M, Van Criekinge W, De Bruine AP, Baldwin HS, Van Engeland M (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24(11):4153–4166 · DOI
  3. Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y, He F (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229(1–2):35–44 · DOI
  4. Ellen TP, Ke Q, Zhang P, Costa M (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29(1):2–8. https://doi.org/10.1093/carcin/bgm200 · DOI
  5. Yao L, Zhang J, Liu X (2008) NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin Shanghai 40(7):625–635 · DOI
  6. Yang X, An L, Li X (2013) NDRG3 and NDRG4, two novel tumor-related genes. Biomed Pharmacother 67(7):681–684. https://doi.org/10.1016/j.biopha.2013.04.009 · DOI
  7. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS, Wang M, Liang P (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279(47):48930–48940 · DOI
  8. Shen L, Qu X, Ma Y, Zheng J, Chu D, Liu B, Li X, Wang M, Xu C, Liu N (2014) Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer. Oncogenesis 3(2):e86 · DOI
  9. Ai R, Sun Y, Guo Z, Wei W, Zhou L, Liu F, Hendricks DT, Xu Y, Zhao X (2016) NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway. Cancer Biol Ther 17(9):943–954 · DOI
  10. Vaes N, Lentjes MHFM, Gijbels MJ, Rademakers G, Daenen KL, Boesmans W, Wouters KAD, Geuzens A, Qu X, Steinbusch HPJ, Rutten BPF, Baldwin SH, Sharkey KA, Hofstra RMW, van Engeland M, Vanden Berghe P, Melotte V (2017) NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons. Neurogastroenterol Motil 29(9). https://doi.org/10.1111/nmo.13095 · DOI
  11. Vaes N, Schonkeren SL, Brosens E, Koch A, McCann CJ, Thapar N, Hofstra RM, van Engeland M, Melotte V (2018) A combined literature and in silico analysis enlightens the role of the NDRG family in the gut. Biochim Biophys Acta Gen Subj · DOI
  12. Okuda T, Kondoh H (1999) Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res Commun 266(1):208–215. https://doi.org/10.1006/bbrc.1999.1780 · DOI
  13. Hu XL, Liu XP, Deng YC, Lin SX, Wu L, Zhang J, Wang LF, Wang XB, Li X, Shen L, Zhang YQ, Yao LB (2006) Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues. Cell Tissue Res 325(1):67–76. https://doi.org/10.1007/s00441-005-0137-5 · DOI
  14. Mitchelmore C, Büchmann-Møller S, Rask L, West MJ, Troncoso JC, Jensen NA (2004) NDRG2: a novel Alzheimer’s disease associated protein. Neurobiol Dis 16(1):48–58 · DOI
  15. Jin P-P, Xia F, Ma B-F, Li Z, Zhang G-F, Deng Y-C, Tu Z-L, Zhang X-X, Hou S-XJAA-AA (2019) Spatiotemporal expression of NDRG2 in the human fetal brain. Ann Anat 221:148–155 · DOI
  16. Pramparo T, Libiger O, Jain S, Li H, Youn YH, Hirotsune S, Schork NJ, Wynshaw-Boris A (2011) Global developmental gene expression and pathway analysis of normal brain development and mouse models of human neuronal migration defects. PLoS Genet 7(3):e1001331. https://doi.org/10.1371/journal.pgen.1001331 · DOI
  17. Wakisaka Y, Furuta A, Masuda K, Morikawa W, Kuwano M, Iwaki T (2003) Cellular distribution of NDRG1 protein in the rat kidney and brain during Normal postnatal development. J Histochem Cytochem 51(11):1515–1525 · DOI
  18. Qu X, Jia H, Garrity DM, Tompkins K, Batts L, Appel B, Zhong TP, Baldwin HS (2008) Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 317(2):486–496. https://doi.org/10.1016/j.ydbio.2008.02.044 · DOI
  19. Maeda A, Hongo S, Miyazaki A (2004) Genomic organization, expression, and comparative analysis of noncoding region of the rat Ndrg4 gene. Gene 324:149–158 · DOI
  20. Nakada N, Hongo S, Ohki T, Maeda A, Takeda M (2002) Molecular characterization of NDRG4/Bdm1 protein isoforms that are differentially regulated during rat brain development. Brain Res Dev Brain Res 135(1–2):45–53 · DOI
  21. Zhou R-H, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73(1):86–97 · DOI
  22. Okuda T, Kokame K, Miyata T (2008) Differential expression patterns of NDRG family proteins in the central nervous system. J Histochem Cytochem 56(2):175–182 · DOI
  23. Berger P, Sirkowski EE, Scherer SS, Suter U (2004) Expression analysis of the N-Myc downstream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom. Neurobiol Dis 17(2):290–299. https://doi.org/10.1016/j.nbd.2004.07.014 · DOI
  24. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118(5):399–408 · DOI
  25. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, De Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy–Lom. Am J Hum Genet 67(1):47–58 · DOI
  26. Flügge G, Araya-Callis C, Garea-Rodriguez E, Stadelmann-Nessler C, Fuchs E (2014) NDRG2 as a marker protein for brain astrocytes. Cell Tissue Res 357(1):31–41 · DOI
  27. Shen L, Zhao Z-Y, Wang Y-Z, Ji S-P, Liu X-P, Liu X-W, Che H-L, Lin W, Li X, Zhang J, Yao L-B (2008) Immunohistochemical detection of Ndrg2 in the mouse nervous system. Neuroreport 19(9):927–931. https://doi.org/10.1097/WNR.0b013e32830163d0 · DOI
  28. Kovacevic Z, Richardson DR (2006) The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27(12):2355–2366 · DOI
  29. Okuda T, Higashi Y, Kokame K, Tanaka C, Kondoh H, Miyata T (2004) Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol Cell Biol 24(9):3949–3956 · DOI
  30. King RH, Chandler D, Lopaticki S, Huang D, Blake J, Muddle JR, Kilpatrick T, Nourallah M, Miyata T, Okuda T, Carter KW, Hunter M, Angelicheva D, Morahan G, Kalaydjieva L (2011) Ndrg1 in development and maintenance of the myelin sheath. Neurobiol Dis 42(3):368–380 · DOI
  31. Tazir M, Bellatache M, Nouioua S, Vallat JM (2013) Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes. J Peripher Nerv Syst 18(2):113–129 · DOI
  32. Miyata S, Hattori T, Shimizu S, Ito A, Tohyama M (2015) Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed Res Int 2015:492367–492326. https://doi.org/10.1155/2015/492367 · DOI
  33. Miyata S, Koyama Y, Takemoto K, Yoshikawa K, Ishikawa T, Taniguchi M, Inoue K, Aoki M, Hori O, Katayama T, Tohyama M (2011) Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS One 6(5):e19859. https://doi.org/10.1371/journal.pone.0019859 · DOI
  34. Takeichi T, Takarada-Iemata M, Hashida K, Sudo H, Okuda T, Kokame K, Hatano T, Takanashi M, Funabe S, Hattori N, Kitamura O, Kitao Y, Hori O (2011) The effect of Ndrg2 expression on astroglial activation. Neurochem Int 59(1):21–27. https://doi.org/10.1016/j.neuint.2011.03.019 · DOI
  35. Li Y, Xu N, Cai L, Gao Z, Shen L, Zhang Q, Hou W, Zhong H, Wang Q, Xiong L (2013) NDRG2 is a novel p53-associated regulator of apoptosis in C6-originated astrocytes exposed to oxygen-glucose deprivation. PLoS One 8(2):e57130. https://doi.org/10.1371/journal.pone.0057130 · DOI
  36. Li Y, Shen L, Cai L, Wang Q, Hou W, Wang F, Zeng Y, Zhao G, Yao L, Xiong L (2011) Spatial–temporal expression of NDRG2 in rat brain after focal cerebral ischemia and reperfusion. Brain Res 1382:252–258 · DOI
  37. Matschke V, Theiss C, Hollmann M, Schulze-Bahr E, Lang F, Seebohm G, Strutz-Seebohm N (2015) NDRG2 phosphorylation provides negative feedback for SGK1-dependent regulation of a kainate receptor in astrocytes. Front Cell Neurosci 9 (OCT) (no pagination) (387) · DOI
  38. Le TM, Takarada-Iemata M, Ta HM, Roboon J, Ishii H, Tamatani T, Kitao Y, Hattori T, Hori OJJon (2018) Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis. J Neurochem 145 (2):139–153
  39. Takahashi K, Ohata H, Honda K, Yamada M (2005) Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells. Neurosci Lett 388(3):157–162 · DOI
  40. Yao Y, Wang W, Jing L, Wang Y, Li M, Hou X, Wang J, Peng T, Teng J, Jia Y (2017) Let-7f regulates the hypoxic response in cerebral ischemia by targeting NDRG3. Neurochem Res 42(2):446–454 · DOI
  41. Jóźwiak-Bebenista M, Bednarek K, Nowak JZ (2008) The neuroprotective effect of PACAP, VIP, and derivatives in brain ischemia. Postepy Hig Med Dosw (Online) 62:478–489
  42. Fontenas L, Chambraud B, Tawk M (2015) Neuronal ndrg4 is essential for nodes of Ranvier organization and myelination in zebrafish. Glia 63:E205–E206
  43. Yamamoto H, Kokame K, Okuda T, Nakajo Y, Yanamoto H, Miyata T (2011) NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia. J Biol Chem 286(29):26158–26165 · DOI
  44. Wen L, Liu L, Tong L, Li J, Zhang K, Zhang Q, Li CJG, Diseases (2019) NDRG4 prevents cerebral ischemia/reperfusion injury by inhibiting neuronal apoptosis. Genes Dis · DOI
  45. Wen L, Liu L, Li J, Tong L, Zhang K, Zhang Q, Li C (2019) NDRG4 protects against cerebral ischemia injury by inhibiting p53-mediated apoptosis. Brain Res Bull 146:104–111 · DOI
  46. Yamauchi Y, Hongo S, Ohashi T, Shioda S, Zhou C, Nakai Y, Nishinaka N, Takahashi R, Takeda F, Takeda M (1999) Molecular cloning and characterization of a novel developmentally regulated gene, Bdm1, showing predominant expression in postnatal rat brain. Mol Brain Res 68(1–2):149–158 · DOI
  47. Ohki T, Hongo S, Nakada N, Maeda A, Takeda M (2002) Inhibition of neurite outgrowth by reduced level of NDRG4 protein in antisense transfected PC12 cells. Brain Res Dev Brain Res 135(1–2):55–63 · DOI
  48. Hongo S, Watanabe T, Takahashi K, Miyazaki A (2006) Ndrg4 enhances NGF-induced ERK activation uncoupled with Elk-1 activation. J Cell Biochem 98(1):185–193 · DOI
  49. Okamoto Y, Goksungur MT, Pehlivan D, Beck CR, Gonzaga-Jauregui C, Muzny DM, Atik MM, Carvalho CM, Matur Z, Bayraktar S (2014) Exonic duplication CNV of NDRG1 associated with autosomal-recessive HMSN-Lom/CMT4D. Genet Med 16(5):386–394 · DOI
  50. Echaniz-Laguna A, Degos B, Bonnet C, Latour P, Hamadouche T, Lévy N, Leheup B (2007) NDRG1-linked Charcot-Marie-tooth disease (CMT4D) with central nervous system involvement. Neuromuscul Disord 17(2):163–168 · DOI
  51. Kumar A, Singh A (2015) A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195–203 · DOI · Paper page
  52. Wang F, Zhong H, Li X, Peng Y, Kinden R, Liang W, Li X, Shi M, Liu L, Wang Q, Xiong L (2014) Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice. Mol Neurobiol 50(2):305–313. https://doi.org/10.1007/s12035-013-8609-1 · DOI
  53. You M-H, Kim BM, Chen C-H, Begley MJ, Cantley LC, Lee TH (2017) Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death. Cell Death Differ 24(2):238–250 · DOI
  54. Rong XF, Sun YN, Liu DM, Yin HJ, Peng Y, Xu SF, Wang L, Wang XL (2017) The pathological roles of NDRG2 in Alzheimer’s disease, a study using animal models and APPwt-overexpressed cells. CNS Neurosci Ther 23(8):667–679 · DOI
  55. Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73(1):86–97. https://doi.org/10.1006/geno.2000.6496 · DOI
  56. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG, Caselli RJ, Kukull WA, McKeel D, Morris JC (2007) Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 28:311–322 · DOI
  57. Herskowitz JH, Seyfried NT, Duong DM, Xia Q, Rees HD, Gearing M, Peng J, Lah JJ, Levey AI (2010) Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res 9(12):6368–6379. https://doi.org/10.1021/pr100666c · DOI
  58. Kotipatruni RP, Ren X, Thotala D, Jaboin JJ (2015) NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells. Oncotarget · DOI
  59. Skiriute D, Tamasauskas S, Asmoniene V, Saferis V, Skauminas K, Deltuva V, Tamasauskas A (2011) Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas. J Neuro-Oncol 102(1):89–94. https://doi.org/10.1007/s11060-010-0291-9 · DOI
  60. Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65(16):7121–7126. https://doi.org/10.1158/0008-5472.can-05-0043 · DOI
  61. Ongaratti B, Silva C, Trott G, Haag T, Leães C, Ferreira N, Oliveira M, Pereira-Lima J (2016) Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence. Braz J Med Biol Res 49(4) · DOI
  62. Kotipatruni RP, Ferraro DJ, Ren X, Vanderwaal RP, Thotala DK, Hallahan DE, Jaboin JJ (2012) NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas. Integr Biol (Camb) 4(10):1185–1197. https://doi.org/10.1039/c2ib20168b · DOI
  63. Li D, Mei H, Qi M, Yang D, Zhao X, Xiang X, Pu J, Huang K, Zheng L, Tong Q (2013) FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma. Oncotarget 4(11):2021 · DOI
  64. Matsushita K, Uchida K, Saigusa S, Ide S, Hashimoto K, Koike Y, Otake K, Inoue M, Tanaka K, Kusunoki M (2013) Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients. Pediatr Surg Int 29(4):363–368. https://doi.org/10.1007/s00383-012-3248-6 · DOI
  65. Li J, Kretzner L (2003) The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N-or c-myc. Mol Cell Biochem 250(1):91–105 · DOI
  66. Li D, Mei H, Pu J, Xiang X, Zhao X, Qu H, Huang K, Zheng L, Tong Q (2015) Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2. Mol Cancer 14(1):47 · DOI
  67. Zhang Z-G, Li G, Feng D-Y, Zhang J, Qin H, Ma L, Gao G, Wu L (2013) Overexpression of NDRG2 can inhibit neuroblastoma cell proliferation through negative regulation by CYR61. Asian Pac J Cancer Prev 15(1):239–244 · DOI
  68. Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310(17):1842–1850. https://doi.org/10.1001/jama.2013.280319 · DOI
  69. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9):494–503; quiz 491 p following 516. https://doi.org/10.1038/ncpneuro0289 · DOI
  70. Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thome CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, Schackert G, Tatagiba M, Westphal M, Tonn JC, Gramatzki D, Pietsch T, Hartmann C, Glimm H, Vajkoczy P, von Deimling A, Platten M, Weller M, Wick W (2014) NDRG1 prognosticates the natural course of disease in WHO grade II glioma. J Neuro-Oncol 117(1):25–32. https://doi.org/10.1007/s11060-013-1357-2 · DOI
  71. Sun B, Chu D, Li W, Chu X, Li Y, Wei D, Li H (2009) Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J Neuro-Oncol 94(2):213–219. https://doi.org/10.1007/s11060-009-9859-7 · DOI
  72. Ma W, Na M, Tang C, Wang H, Lin Z (2015) Overexpression of Nmyc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3kinase/AKT pathways. Mol Med Rep 12(1):1050–1058 · DOI
  73. Said HM, Stein S, Hagemann C, Polat B, Staab A, Anacker J, Schoemig B, Theobald M, Flentje M, Vordermark D (2009) Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Oncol Rep 21(1):237–246
  74. Weiler M, Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, Bunse L, Solecki G, Eichwald V, Jugold M (2014) mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proc Natl Acad Sci U S A 111 (1):409–414 · DOI
  75. Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu X, Au W, Wang J, Li F, Ji S (2003) N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106(3):342–347 · DOI
  76. Li W, Chu D, Chu X, Meng F, Wei D, Li H, Sun B (2011) Decreased expression of NDRG2 is related to poor overall survival in patients with glioma. J Clin Neurosci 18(11):1534–1537. https://doi.org/10.1016/j.jocn.2010.12.032 · DOI
  77. Skiriute D, Vaitkiene P, Asmoniene V, Steponaitis G, Deltuva VP, Tamasauskas A (2013) Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma. J Neuro-Oncol 113(3):441–449 · DOI
  78. Tepel M, Roerig P, Wolter M, Gutmann DH, Perry A, Reifenberger G, Riemenschneider MJ (2008) Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11. 2 in primary glioblastoma. Int J Cancer 123(9):2080–2086 · DOI
  79. Zhou B, Tang Z, Deng Y, Hou S, Liu N, Lin W, Liu X, Yao L (2014) Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme. Mol Med Rep 10(2):891–896 · DOI
  80. Skiriutė D, Steponaitis G, Vaitkienė P, Mikučiūnas M, Skauminas K, Tamašauskas A, Kazlauskas A (2014) Glioma malignancy-dependent NDRG2 gene methylation and downregulation correlates with poor patient outcome. J Cancer 5(6):446–456 · DOI
  81. Ding W, Zhang J, Yoon JG, Shi D, Foltz G, Lin B (2012) NDRG4 is downregulated in glioblastoma and inhibits cell proliferation. OMICS 16(5):263–267. https://doi.org/10.1089/omi.2011.0146 · DOI
  82. Schilling SH, Hjelmeland AB, Radiloff DR, Liu IM, Wakeman TP, Fielhauer JR, Foster EH, Lathia JD, Rich JN, Wang XF, Datto MB (2009) NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem 284(37):25160–25169. https://doi.org/10.1074/jbc.M109.012484 · DOI
  83. Kolodziej MA, Weischer C, Reinges MH, Uhl E, Weigand MA, Schwarm FP, Schanzer A, Acker T, Quint K, Uhle F, Stein M (2016) NDRG2 and NDRG4 expression is altered in glioblastoma and influences survival in patients with MGMT-methylated tumors. Anticancer Res 36(3):887–897
  84. Li S, Yang B, Li G, He S, Li Y (2013) Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas. Brain Tumor Pathol 30(1):8–14. https://doi.org/10.1007/s10014-012-0092-2 · DOI
  85. Du Z, Niu S, Xu X, Xu Q (2017) MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance. Cancer Biomark 19(2):221–230. https://doi.org/10.3233/cbm-170568 · DOI
  86. Ren GF, Tang L, Yang AQ, Jiang WW, Huang YM (2014) Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy. Histol Histopathol 29(4):535–542. https://doi.org/10.14670/hh-29.10.535 · DOI
  87. Ma J, Liu S, Zhang W, Zhang F, Wang S, Wu L, Yan R, Wu L, Wang C, Zha Z, Sun J (2016) High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma. Pathol 48(7):691–696. https://doi.org/10.1016/j.pathol.2016.08.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Schonkeren, S. L., Massen, M., van der Horst, R., Koch, A., Vaes, N., & Melotte, V.
Venue
neurogenetics
Publisher
Springer Science and Business Media LLC
Published
2019-09-04
Volume
20
Issue
4
Pages
173-186
ISSN
  • 1364-6745
  • 1364-6753
DOI
10.1007/s10048-019-00587-0
PMC
PMC6754360
Cited by
57
References
5
Language
en
Licence
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.186.124)
  • KWF Kankerbestrijding (UM 2013-6075)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review